Fundraising FoxRhoshan Pharmaceuticals
State College, US · Founded 2018 · Delaware corporation
Find your way into Rhoshan Pharmaceuticals
Sign up to see every warm intro you have to Rhoshan Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rhoshan Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rhoshan Pharmaceuticals develops injectable formulations of commonly used oral drugs.
Founders & leadership
HP
CM
Charlene MessingerExecutive
AC
Allan ClarkeExecutive
NP
Nagesh PalepuNamed on SEC filing
KJ
Kevin J. O'NeillNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$23.8M disclosed across 3 rounds · 2018–2023
▶$3.1MraisedJul 2026 · 4 investors · PharmaceuticalsRule 506(b)
▶$3.1MraisedJul 2026 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Hitha PalepuExecutive Officer, Director
- Nagesh PalepuDirector
- Allan ClarkeExecutive Officer, Director
- Charlene MessingerExecutive Officer
- Offering amount
- $3.2M
- Amount sold
- $3.1M
- Proceeds to insiders
- $216K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedSep 2019 · 5 investors · BiotechnologyRule 506(b)
▶$1.4MraisedSep 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hitha PalepuExecutive Officer, Director
- Kevin J. O'NeillExecutive Officer, Director
- Nagesh PalepuExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.4M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$19.3MraisedDec 2018 · BiotechnologyRule 506(b)
▶$19.3MraisedDec 2018 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin J. O'NeillExecutive Officer, Director
- Hitha PalepuExecutive Officer, Director
- Nagesh PalepuExecutive Officer, Director
- Offering amount
- $19.3M
- Amount sold
- $19.3M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Rhoshan Pharmaceuticals do?
- Rhoshan Pharmaceuticals develops injectable formulations of commonly used oral drugs.
- How much funding has Rhoshan Pharmaceuticals raised?
- Rhoshan Pharmaceuticals has disclosed $23.8M raised across 3 rounds.
- Where is Rhoshan Pharmaceuticals headquartered?
- Rhoshan Pharmaceuticals is headquartered in State College, US.